Gastroesophageal Reflux Disease or Proton Pump Inhibitor Use?: A Controversy Over the Association of Nontuberculous Mycobacterial Pulmonary Disease

Chest. 2023 Mar;163(3):e147-e148. doi: 10.1016/j.chest.2022.11.036.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Gastroesophageal Reflux* / drug therapy
  • Humans
  • Lung Diseases*
  • Proton Pump Inhibitors / adverse effects

Substances

  • Proton Pump Inhibitors